Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics Companies 2012-2018

Dublin, March 07, 2018 -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018" report has been added to ResearchAndMarkets.com's offering.

The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies.

This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report covers details of co-promotion and co-marketing agreements from 2012 to 2018.

For pharmaceutical and biotechnology professionals, the report supplies a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of all co-promotion and co-marketing deals announced since 2012 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Key benefits

• In-depth understanding of co-promotion and co-marketing deal trends since 2012
• Analysis of the structure of co-promotion and co-marketing agreements with numerous real life case studies
• Comprehensive access to over 700 actual co-promotion and co-marketing deals entered into by the world's biopharma companies
• Insight into the terms included in a co-promotion and co-marketing agreement, together with real world clause examples
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

• Trends in co-promotion and co-marketing dealmaking in the biopharma industry since 2012
• Analysis of co-promotion and co-marketing deal structure
• Case studies of real-life co-promotion and co-marketing deals
• Access to over 700 co-promotion and co-marketing deal records
• Detailed access to actual co-promotion contract documents
• The leading co-promotion and co-marketing deals by value since 2012
• Most active co-promotion and co-marketing dealmakers since 2012
• The leading co-promotion and co-marketing partnering resources

The available contracts are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Therapeutic area
• Technology area

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

Chapter 3 - Overview of co-promotion deal structure

Chapter 4 - Overview of co-marketing deal structure

Chapter 5 - Leading co-promotion and co-marketing deals

Chapter 6 - Top 50 most active co-promotion and co-marketing dealmakers

Chapter 7 - Co-promotion and co-marketing agreement contracts directory 2012- 2018

For more information about this report visit https://www.researchandmarkets.com/research/cghgff/global?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Biotechnology, Pharmaceuticals, Diagnostics